Tag Archives: NASDAQ:SRPT

Healthcare Hot Stocks under Spotlight: Astex, ZIOPHARM Oncology, Alkermes, NeoStem, Sarepta Therapeutics, Novavax, Amgen

economyAstex Pharmaceuticals, Inc (NASDAQ:ASTX) on Friday declared that chairman and CEO James S.J. Manuso and MD and chief medical officer Mohammad Azab was present at the Jefferies 2013 Global Healthcare Conference on Wednesday June 5th in New York City.

buy
Posted in Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off

Sanofi’s (NYSE:SNY) Genzyme Division Gets Approval for Thyrogen – SNY, MRK, PFE, GALE, ACRX, JNJ, ACHC, SRPT, ABT

Sanofi’s(NYSE:SNY) Genzyme division has got European Commission authorization of a product label development for the use of Thyrogen, its cure for thyroid cancer.

Thyrogen is used to cure patients with well-distinguished thyroid cancer. The drug is accepted as an adjunctive …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Bernstein Research Analysts Shatters Boston Scientific (NYSE:BSX) Stock Rating to Market Perform – BSX, JNJ, ABT, ACAD, PFE, MYL, MRK, BMY, SRPT

Boston Scientific Corporation (NYSE:BSX) stock rating was shattered by Bernstein Research analysts on Tuesday to market-perform from their prior rating of outperform.

Analyst of the Bernstein Research kept their price target on the company stock at $6 per share.

Analyst …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

UnitedHealth (NYSE:UNH) 2013 Profit Forecasts Misses Wall Street Estimates – UNH, AET, HUM, BSX, SRPT, CTIC, PFE, ARNA, JNJ

UnitedHealth Group Inc (NYSE:UNH), the biggest United States private health insurer, reported on Monday that it projected earnings in the range of $5.25 to $5.50 a share in 2013, lower than analysts’ forecasts.

The company reported that revenue should be …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

GlaxoSmithKline (NYSE:GSK) Plans to Buy Additional Stock in Indian Unit – GSK, MRK, NVS, SRPT, CTIC, SQNM, ESRX, STJ, GILD

GlaxoSmithKline PLC (NYSE:GSK)has shown interest in purchasing a further stake of almost 31.8% in its Indian division, GlaxoSmithKline Consumer Healthcare Ltd. , at 3,900 rupees ($70.3) a share, the UK-located firm stated in a report on Monday.

The proposal is …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Quick Snapshot of Healthcare Sector; NuVasive (NUVA) Disappoints Investors with Q3 Revenue Forecast while CollabRx (CLRX) Inks Deal with Life Technologies (LIFE) – NUVA, LIFE, PFE, SRPT, BIOL, RIGL

Healthcare sector responded positively on Wednesday’s trading session and sector surged +0.39%. If we look at the top movers of the sector so Sarepta Therapeutics Inc. (NASDAQ:SRPT) and BIOLASE Inc. (NASDAQ:BIOL) were major percentage gainers while major percentage Loser was …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , | Comments Off